Comparative Effects of Focused and Radial Shock-Wave Therapies in Hip Osteoarthritis.
1 other identifier
interventional
150
1 country
1
Brief Summary
There is no scientific study in the literature regarding the use of shock wave therapy in hip osteoarthritis. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in hip osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 18, 2022
CompletedFirst Posted
Study publicly available on registry
February 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedNovember 29, 2022
November 1, 2022
8 months
January 18, 2022
November 28, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Visual Analogue Scale (VAS)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome.
at baseline.
Visual Analogue Scale (VAS)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome
4 weeks after baseline.
Visual Analogue Scale (VAS)
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse outcome.
8 weeks after baseline.
Secondary Outcomes (3)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
at baseline.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
4 weeks after baseline.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
8 weeks after baseline.
Study Arms (3)
Large-Focused Extracorporeal Shock Wave Therapy
ACTIVE COMPARATORControlled-Unfocused Extracorporeal Shock Wave Therapy
ACTIVE COMPARATORSham Extracorporeal Shock Wave Therapy
SHAM COMPARATORInterventions
The ESWT device is product of Elettronica Pagani, Italy.
Eligibility Criteria
You may qualify if:
- unilateral or bilateral hip osteoarthritis
You may not qualify if:
- other disorders that are contraindications for shockwave therapy, not have received ESWT treatment before
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Volkan Şah
Van, 65040, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Volkan Şah
Yüzüncü Yıl Üniversitesi Tıp Fakültesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 18, 2022
First Posted
February 4, 2022
Study Start
January 1, 2022
Primary Completion
August 29, 2022
Study Completion
September 30, 2022
Last Updated
November 29, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share